A d v a n c i n g H e a l t h E c o n o m i c s , S e r v i c e s , P o l i c y a n d E t h i c s

A rem-ARCC-able Update

Dr. Jeffrey Hoch1,4,5

Sarah Benn1,4

Dr. Stuart Peacock1,2

Kimberly van der Hoek1,2

1. Canadian Centre for Applied Research in Cancer Control (ARCC), 2. British Columbia Cancer Agency, 3. University of British Columbia, 4. Cancer Care Ontario, 5. University of Toronto

*

*

Canadian Centre for Applied

Research in Cancer Control (ARCC)

ARCC Network

Program Leads

Investigators Associates

Network Members

Health Technology Assessment

Murray Krahn & Jeffrey Hoch

Health Systems, Services & Policy

Craig Earle & Mary McBride

Societal Values Public Engagement

Jennifer Gibson & Stuart Peacock

Patients & Families

Christopher Longo & Arminee Kazanjian

Knowledge Translation Research

Melissa Brouwers

Research Areas and Program Leads

Canadian Centre for Applied

Research in Cancer Control (ARCC)

ARCC Network

Program Leads

Investigators Associates

Network Members

• Lisa Barbera

• George Browman

• Mark Elwood

• Jennifer Gibson

• David Hodgson

• Nicole Mitttman

• Carol Sawka

• Beth Kapusta

• Morris Barer

• Tony Culyer

• Neil Hagen

• Murray Krahn

• Steve Morgan

• Terry Sullivan

• Scott Berry

• Matt Dobrow

• Konrad Fassbender

• Bart Harvey

• Louise Lemieux -Charles

• Susan O’Reilly

• Simon Sutcliffe

• Melissa Brouwers

• Richard Doll

• David Henry

• Mary McBride

• Jolie Ringash

• Ross Upshur

• Bob Evans

ARCC Investigators

Canadian Centre for Applied

Research in Cancer Control (ARCC)

ARCC Network

Program Leads

Investigators Associates

Network Members

• Nick Bansback

• Shawn Budgen

• Natasha Leighl

• Kimberly McGrail

• Erin Strumpf

• Greg Zaric

• Yvonne Bombard

• Roger Chafe

• Eva Grunfeld

• Geoffrey Liu

• Craig Mitton

• Rosie Thein

• Michael Burgess

• Marc Brisson

• Craig Earle

• Jennifer Jones

• Christopher Longo

• Chris Skedgel

• Frances Wong

• Stirling Bryan

• Lise Fillion

• Arminee Kazanjian

• Deborah Marshall

• Hsien Seow

• Dominika Wranik

ARCC Associates

Canadian Centre for Applied

Research in Cancer Control (ARCC)

ARCC Network

Program Leads

Investigators Associates

Network Members

• Academics

• Researchers

• Students

• Clinicians

• Policy makers

• Decision makers

ARCC Network Members

ARCC enables and enhances research

ARCC enables research

– By making it possible

How we do it?

– Seed grant competitions

– Strategic investments

ARCC enhances research

– By engaging different researchers to work collaboratively

How we do it?

– “match making”

– ARCC Network

– Capacity building

*

Picture of our HTA work

*

www.cc-arcc.com/network/presentations

*

Members Benefit From ARCC

Database ARCC Get

Connected

ARCC

Newsletter- landmARCC

Canada wide resource

Conferences, workshops &

seminars

Grants

ARCC 2012 Conference

Costing Session

*

A Variety of Resources for HTA

ARCC

Connect with

decision makers

Expand your research network

Funding Opportunities

Mentorship

A d v a n c i n g H e a l t h E c o n o m i c s , S e r v i c e s , Po l i c y a n d E t h i c s

How would you like to get involved?

Contact us For more information about ARCC please see our website at www.cc-arcc.ca or contact us at arcc@cancercare.on.ca

BC Cancer Research Centre (BCCA) Cancer Care Ontario (CCO)

675 West 10th Ave 620 University Ave

Vancouver, BC V5Z 1L3 Toronto, ON M5G 2L7

604-675-8000 x7054 416-971-9800 x1 3738

Phase-specific and lifetime costs of cancer in British Columbia and Ontario Principal Investigator: Krahn M Co-Investigators: Shabbir A, Barer M , Farahati F, Hoch J , Laporte A, Machado M, Naglie G, Paszat L, Peacock S , Tomlinson

The cost-effectiveness of intensity-modulated radiation therapy (IMRT) Principal Investigator: Hoch J.

Early detection of lung cancer – a pan-Canadian study Principal Investigator: Lam S Co-Investigators: Tsao MS, Yee J, McWilliams A, Mayo J, Peacock S , Finley R, Evans K, Sin D, Wan T, Burrows P, Liu G, Tremblay A, MacEachern P, Evans B, Tammemagi M, Goffin J, Roberts H, Shepherd F, Sophrati K, Thenganatt J, Leighl N, Puksa S, Stewart L, Goss G, Nicholas G, Laberge F, Gingras M, Johnston M, Seely J, Manos D, Amjadi K, Martel S

Cancer Pharmacoeconomics Evaluation and Research Program Principal Investigator: Hoch J.

The cost-effectiveness of cancer drugs funded by the New Drug Funding Program: providing evidence of the value of medicines in delivering expected outcomes

Principal Investigator: Hoch J , Krahn M

Co-Investigators: Bell C, Gavura S, Grootendorst P, Hodgson D , Mamdani M, Peacock S , Sawka C , Sullivan T , Trudeau M, Woodward G

Genomic, Imaging and Modelling Approaches to Advance Population-Based Colorectal Cancer Screening

Principal Investigator: Tai I

Co-Investigators: Coldman A, Macaulay C, Peacock S , Elwood M , Zeng H

(A) – ARCC funded research

* – Other funding

HTA Research

A 2-year follow-up study of the health effects of androgen deprivation therapy in men with non-metastatic prostate cancer

Principal Investigator: Alibhai, S

Co-investigators: Fleshner N, Krahn M, Naglie G

Androgen deprivation therapy in prostate cancer patients: patterns of care, lifetime costs, and cost effectiveness of ADT treatment

Principal Investigator: Krahn M

Co-investigators: Alibhai S, Laporte A, Naglie G, Tomlinson G, Trachtenberg J, Warde P.

A Randomized Controlled Evaluation of HPV Testing for Cervical Cancer Screening

Principal Investigator: Coldman A

Co-Investigators: Davies P, Martin R, Matisic J, van Niekerk D, Ogilvie G, Ehlen T, Stuart G, Franco E, Peacock S , Krajden M

From Disease Gene Mapping to Clinical Practice – A Provincial Program in Clinical Genomics

Principal Investigator: Siminovitch K.

Co-Investigators: Heathcote J, Ozcelik H, Laurent B.

Post-doctoral fellow: Djalalov, Sandjar

Optical Techniques and Oral Pre-cancer Management

Principal Investigator: Rosin MP

Co-Investigators: Garner D, Guillaud M, Hislop TG, Lane P, Le ND, Macaulay C, Peacock S , Poh C, Williams PM, Zhang

Cost-effectiveness of erlotinib for 2nd and 3rd line use in metastatic lung cancer

Principal Investigator: Peacock S

Co-Investigators: van der Hoek K , Melosky B, Taylor S, Johnston K, Cromwell I

HTA Research Continued

Valuing cancer interventions: is there a cancer premium?

Principal Investigator: Peacock, S

Co-Investigators: Gibson, J, Teckle P

Comparisons in costs of end-of-life care in lung cancer patients in Ontario and the United States

Principal Investigators: Krahn M

Co-Investigators: Barbera L, Hoch J, Warren J, Yabroff R

HTA Research Continued